PLUS1
37.03
0.00 (0.0%)
0.00 (0.0%)
Upgrade to Real-Time
Premarket
| Volume | 0 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
Best deals to access real time data! |
|
CHART Trader
Monthly Subscription
for only
|
|
Canadian Level 1 + USA
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| iTeos Therapeutics Inc | ITOS | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
 |
|
|---|---|---|---|---|
| 0.00 | 0.0% | 37.03 | 06:24:54 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 37.03 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| - | 0 | $ 37.03 | USD |
Period:
Draw Mode:
iTeos Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 1.31B | 35.27M | 20.18M | $ - | $ - | -0.49 | 32.00 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | -1.42M | 0.40% |
iTeos Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ITOS Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 40.37 | 41.00 | 36.57 | 38.60 | 450,515 | -3.34 | -8.27% |
| 1 Month | 46.26 | 52.43 | 36.57 | 43.33 | 893,075 | -9.23 | -19.95% |
| 3 Months | 27.02 | 52.43 | 26.21 | 40.11 | 502,268 | 10.01 | 37.05% |
| 6 Months | 24.00 | 52.43 | 23.42 | 36.08 | 316,701 | 13.03 | 54.29% |
| 1 Year | 36.89 | 52.43 | 17.43 | 31.62 | 354,136 | 0.14 | 0.38% |
| 3 Years | 19.70 | 52.43 | 17.43 | 30.87 | 293,308 | 17.33 | 87.97% |
| 5 Years | 19.70 | 52.43 | 17.43 | 30.87 | 293,308 | 17.33 | 87.97% |
iTeos Therapeutics Description
| ITeos Therapeutics Inc is a biopharmaceutical company engaged in the discovery and development of immuno-oncology therapeutics for patients. Its product candidates include EOS-850 which is an Adenosine A2A receptor-specific antagonist and EOS-448 which is an ADCC-enabled, anti-TIGIT immune checkpoint blocking antibody. |
